Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
$13.81
+3.5%
$12.90
$6.09
▼
$15.66
$5.51B1.356.65 million shs5.62 million shs
Option Care Health, Inc. stock logo
OPCH
Option Care Health
$31.59
-0.1%
$28.87
$18.01
▼
$36.80
$4.75B0.473.48 million shs2.95 million shs
RadNet, Inc. stock logo
RDNT
RadNet
$69.71
+0.3%
$72.71
$50.82
▼
$85.84
$6.06B1.42764,594 shs594,238 shs
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$45.46
-7.7%
$70.18
$32.21
▼
$170.87
$1.53B21.14 million shs912,293 shs
Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
+3.52%-1.92%+12.00%+10.75%+123.46%
Option Care Health, Inc. stock logo
OPCH
Option Care Health
-0.06%-0.19%+0.96%+33.29%+13.76%
RadNet, Inc. stock logo
RDNT
RadNet
+0.29%-8.78%+1.90%-9.26%-13.18%
GeneDx Holdings Corp. stock logo
WGS
GeneDx
-7.68%-13.19%-34.06%-47.79%-65.98%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
$13.81
+3.5%
$12.90
$6.09
▼
$15.66
$5.51B1.356.65 million shs5.62 million shs
Option Care Health, Inc. stock logo
OPCH
Option Care Health
$31.59
-0.1%
$28.87
$18.01
▼
$36.80
$4.75B0.473.48 million shs2.95 million shs
RadNet, Inc. stock logo
RDNT
RadNet
$69.71
+0.3%
$72.71
$50.82
▼
$85.84
$6.06B1.42764,594 shs594,238 shs
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$45.46
-7.7%
$70.18
$32.21
▼
$170.87
$1.53B21.14 million shs912,293 shs
Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
+3.52%-1.92%+12.00%+10.75%+123.46%
Option Care Health, Inc. stock logo
OPCH
Option Care Health
-0.06%-0.19%+0.96%+33.29%+13.76%
RadNet, Inc. stock logo
RDNT
RadNet
+0.29%-8.78%+1.90%-9.26%-13.18%
GeneDx Holdings Corp. stock logo
WGS
GeneDx
-7.68%-13.19%-34.06%-47.79%-65.98%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
2.70
Moderate Buy$14.867.58% Upside
Option Care Health, Inc. stock logo
OPCH
Option Care Health
2.13
Hold$29.48-6.69% Downside
RadNet, Inc. stock logo
RDNT
RadNet
2.78
Moderate Buy$89.6728.63% Upside
GeneDx Holdings Corp. stock logo
WGS
GeneDx
2.89
Moderate Buy$90.1498.29% Upside

Current Analyst Ratings Breakdown

Latest WGS, RDNT, LFST, and OPCH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/18/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Reiterated RatingBuy$85.00
11/16/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
UpgradeHold ➝ Strong-Buy
11/12/2026
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
Boost Price TargetNeutral$13.00 ➝ $15.00
11/10/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Reiterated RatingBuy$90.00 ➝ $85.00
11/10/2026
RadNet, Inc. stock logo
RDNT
RadNet
Boost Price TargetOverweight$92.00 ➝ $95.00
11/9/2026
RadNet, Inc. stock logo
RDNT
RadNet
DowngradeStrong-Buy ➝ Hold
11/6/2026
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
Boost Price TargetBuy$15.00 ➝ $16.00
11/6/2026
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
Boost Price TargetOverweight$15.00 ➝ $17.00
11/5/2026
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
Boost Price TargetBuy$18.00 ➝ $20.00
11/4/2026
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
Reiterated RatingHold (C)
11/4/2026
RadNet, Inc. stock logo
RDNT
RadNet
Reiterated RatingSell (D-)
(Data available from 11/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
$1.42B3.69$0.16 per share86.08$3.93 per share3.51
Option Care Health, Inc. stock logo
OPCH
Option Care Health
$5.65B0.84$2.04 per share15.52$8.84 per share3.57
RadNet, Inc. stock logo
RDNT
RadNet
$2.04B2.69$2.92 per share23.85$18.24 per share3.82
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$427.54M3.19$2.04 per share22.26$8.16 per share5.57
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
$9.66M$0.1972.6951.15N/A4.29%4.82%3.30%N/A
Option Care Health, Inc. stock logo
OPCH
Option Care Health
$207.59M$1.3922.7316.711.933.74%19.06%7.32%N/A
RadNet, Inc. stock logo
RDNT
RadNet
-$18.65M-$0.29N/A69.02N/A-0.94%3.14%1.08%N/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
-$21.02M-$3.78N/A36.08N/A-24.10%1.98%1.02%N/A

Latest WGS, RDNT, LFST, and OPCH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/9/2026Q3 2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$0.0729$0.28+$0.2071-$0.41$122.93 million$123.10 million
11/8/2026Q3 2026
RadNet, Inc. stock logo
RDNT
RadNet
$0.2214$0.30+$0.0786$0.05$639.97 million$638.26 million
11/5/2026Q3 2026
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
$0.0369$0.06+$0.0231$0.06$431.59 million$455.86 million
11/4/2026Q3 2026
Option Care Health, Inc. stock logo
OPCH
Option Care Health
$0.4894$0.49+$0.0006$0.38$1.48 billion$1.49 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
N/AN/AN/AN/AN/A
Option Care Health, Inc. stock logo
OPCH
Option Care Health
N/AN/AN/AN/AN/A
RadNet, Inc. stock logo
RDNT
RadNet
N/AN/AN/AN/AN/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
0.17
1.44
1.44
Option Care Health, Inc. stock logo
OPCH
Option Care Health
0.87
1.54
1.06
RadNet, Inc. stock logo
RDNT
RadNet
0.90
1.49
1.49
GeneDx Holdings Corp. stock logo
WGS
GeneDx
0.60
4.16
3.85

Institutional Ownership

CompanyInstitutional Ownership
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
85.50%
Option Care Health, Inc. stock logo
OPCH
Option Care Health
98.05%
RadNet, Inc. stock logo
RDNT
RadNet
77.90%
GeneDx Holdings Corp. stock logo
WGS
GeneDx
61.72%

Insider Ownership

CompanyInsider Ownership
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
3.50%
Option Care Health, Inc. stock logo
OPCH
Option Care Health
1.70%
RadNet, Inc. stock logo
RDNT
RadNet
5.14%
GeneDx Holdings Corp. stock logo
WGS
GeneDx
25.17%
CompanyEmployeesShares OutstandingFree FloatOptionable
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
10,961380.19 million366.88 millionOptionable
Option Care Health, Inc. stock logo
OPCH
Option Care Health
8,266149.80 million147.25 millionOptionable
RadNet, Inc. stock logo
RDNT
RadNet
11,26478.78 million74.73 millionOptionable
GeneDx Holdings Corp. stock logo
WGS
GeneDx
1,30029.97 million22.43 millionOptionable

Recent News About These Companies

GeneDx (NASDAQ:WGS) Stock Rating Reaffirmed as Buy by BTIG Research
GeneDx Announces Leadership Transition - November 18, 2026
GeneDx Holdings Corp. Announces Management Changes
GeneDx (NASDAQ:WGS) Shares Climb 8.8% - What's Next?
GeneDx (NASDAQ:WGS) Earns "Buy" Rating from BTIG Research
GeneDx Announces Leadership Transition
GeneDx (NASDAQ:WGS) Stock Rating Upgraded by Zacks Research
GeneDx Earnings Call Highlights Growth and Profitability
GeneDx to Participate in Upcoming Investor Conferences
GeneDx Sees Unusually High Options Volume (NASDAQ:WGS)
Why GeneDx Holdings Stock Just Dropped 16.6%
4 Post-Earnings Losers Drawing Unusual Options Volume
GeneDx (NASDAQ:WGS) Shares Gap Down - Here's Why
GeneDx (WGS) Q3 2026 Earnings Call Transcript

New MarketBeat Followers Over Time

Media Sentiment Over Time

LifeStance Health Group stock logo

LifeStance Health Group NASDAQ:LFST

$13.81 +0.47 (+3.52%)
Closing price 11/20/2026 03:58 PM Eastern
Extended Trading
$13.63 -0.18 (-1.33%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

Option Care Health stock logo

Option Care Health NASDAQ:OPCH

$31.59 -0.02 (-0.06%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$31.58 -0.01 (-0.03%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

RadNet stock logo

RadNet NASDAQ:RDNT

$69.71 +0.20 (+0.29%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$69.59 -0.12 (-0.17%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

GeneDx stock logo

GeneDx NASDAQ:WGS

$45.46 -3.78 (-7.68%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$45.42 -0.04 (-0.09%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.